BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20813409)

  • 21. The cuprizone model: regional heterogeneity of pathology.
    Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
    APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCR3 modulates glial accumulation and activation in cuprizone-induced demyelination of the central nervous system.
    Krauthausen M; Saxe S; Zimmermann J; Emrich M; Heneka MT; Müller M
    J Neuroinflammation; 2014 Jun; 11():109. PubMed ID: 24930935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous administration of human embryonic stem cell-derived neural precursor cells attenuates cuprizone-induced central nervous system (CNS) demyelination.
    Crocker SJ; Bajpai R; Moore CS; Frausto RF; Brown GD; Pagarigan RR; Whitton JL; Terskikh AV
    Neuropathol Appl Neurobiol; 2011 Oct; 37(6):643-53. PubMed ID: 21276029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination.
    Hibbits N; Yoshino J; Le TQ; Armstrong RC
    ASN Neuro; 2012 Oct; 4(6):393-408. PubMed ID: 23025787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRPA1 deficiency is protective in cuprizone-induced demyelination-A new target against oligodendrocyte apoptosis.
    Sághy É; Sipos É; Ács P; Bölcskei K; Pohóczky K; Kemény Á; Sándor Z; Szőke É; Sétáló G; Komoly S; Pintér E
    Glia; 2016 Dec; 64(12):2166-2180. PubMed ID: 27568827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effect of Stereotactic Injections on Demyelination and Remyelination: a Study in the Cuprizone Model.
    Tejedor LS; Wostradowski T; Gingele S; Skripuletz T; Gudi V; Stangel M
    J Mol Neurosci; 2017 Apr; 61(4):479-488. PubMed ID: 28124770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure.
    Ray AK; DuBois JC; Gruber RC; Guzik HM; Gulinello ME; Perumal G; Raine C; Kozakiewicz L; Williamson J; Shafit-Zagardo B
    Glia; 2017 Dec; 65(12):2051-2069. PubMed ID: 28925029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deletion of Voltage-Gated Calcium Channels in Astrocytes during Demyelination Reduces Brain Inflammation and Promotes Myelin Regeneration in Mice.
    Zamora NN; Cheli VT; Santiago González DA; Wan R; Paez PM
    J Neurosci; 2020 Apr; 40(17):3332-3347. PubMed ID: 32169969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 17beta-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss.
    Taylor LC; Puranam K; Gilmore W; Ting JP; Matsushima GK
    Neurobiol Dis; 2010 Aug; 39(2):127-37. PubMed ID: 20347981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune cell-derived C3a and C5a costimulate human T cell alloimmunity.
    Cravedi P; Leventhal J; Lakhani P; Ward SC; Donovan MJ; Heeger PS
    Am J Transplant; 2013 Oct; 13(10):2530-9. PubMed ID: 24033923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization.
    Chen MK; Baidoo K; Verina T; Guilarte TR
    Brain; 2004 Jun; 127(Pt 6):1379-92. PubMed ID: 15069023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of reactive astrocytes fosters tissue regeneration after cuprizone-induced demyelination.
    Schröder LJ; Mulenge F; Pavlou A; Skripuletz T; Stangel M; Gudi V; Kalinke U
    Glia; 2023 Nov; 71(11):2573-2590. PubMed ID: 37455566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination.
    Brück W; Pförtner R; Pham T; Zhang J; Hayardeny L; Piryatinsky V; Hanisch UK; Regen T; van Rossum D; Brakelmann L; Hagemeier K; Kuhlmann T; Stadelmann C; John GR; Kramann N; Wegner C
    Acta Neuropathol; 2012 Sep; 124(3):411-24. PubMed ID: 22766690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.
    Skripuletz T; Lindner M; Kotsiari A; Garde N; Fokuhl J; Linsmeier F; Trebst C; Stangel M
    Am J Pathol; 2008 Apr; 172(4):1053-61. PubMed ID: 18349131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-17A Promotes Granulocyte Infiltration, Myelin Loss, Microglia Activation, and Behavioral Deficits During Cuprizone-Induced Demyelination.
    Zimmermann J; Emrich M; Krauthausen M; Saxe S; Nitsch L; Heneka MT; Campbell IL; Müller M
    Mol Neurobiol; 2018 Feb; 55(2):946-957. PubMed ID: 28084589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two different transduction pathways are activated by C3a and C5a anaphylatoxins on astrocytes.
    Sayah S; Jauneau AC; Patte C; Tonon MC; Vaudry H; Fontaine M
    Brain Res Mol Brain Res; 2003 Apr; 112(1-2):53-60. PubMed ID: 12670702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unconventional Myosin ID is Involved in Remyelination After Cuprizone-Induced Demyelination.
    Yamazaki R; Baba H; Yamaguchi Y
    Neurochem Res; 2018 Jan; 43(1):195-204. PubMed ID: 28986688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis.
    Liu L; Belkadi A; Darnall L; Hu T; Drescher C; Cotleur AC; Padovani-Claudio D; He T; Choi K; Lane TE; Miller RH; Ransohoff RM
    Nat Neurosci; 2010 Mar; 13(3):319-26. PubMed ID: 20154684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of branched O-mannosyl glycans in astrocytes accelerates remyelination.
    Kanekiyo K; Inamori K; Kitazume S; Sato K; Maeda J; Higuchi M; Kizuka Y; Korekane H; Matsuo I; Honke K; Taniguchi N
    J Neurosci; 2013 Jun; 33(24):10037-47. PubMed ID: 23761899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental Demyelination and Axonal Loss Are Reduced in MicroRNA-146a Deficient Mice.
    Martin NA; Molnar V; Szilagyi GT; Elkjaer ML; Nawrocki A; Okarmus J; Wlodarczyk A; Thygesen EK; Palkovits M; Gallyas F; Larsen MR; Lassmann H; Benedikz E; Owens T; Svenningsen AF; Illes Z
    Front Immunol; 2018; 9():490. PubMed ID: 29593734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.